Showing results (131-140 of 216) with videos related to
Sort By:
Pageof 22
Annals of Surgical Oncology|May 9, 2025
Postoperative Recurrence Pattern of Clinical Stage I Esophageal Cancer After Esophagectomy with Two- or Three-Field Lymph Node Dissection: Supplementary Analysis from JCOG0502Takeo Bamba, Ken Kato, Hiroyuki Daiko, et al.Radiation Oncology (London, England)|February 29, 2016
Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancerKen Hatogai, Tomonori Yano, Takashi Kojima, et al.Cancer Chemotherapy and Pharmacology|August 5, 2020
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapyHisanaga Nomura, Daiki Tsuji, Ken Demachi, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 12, 2011
Clinicopathological features of stomach cancer with invasive micropapillary componentTakeo Fujita, Naoto Gotohda, Yuichiro Kato, et al.Anticancer Research|December 29, 2018
Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell CarcinomaShin Nishiumi, Seiji Fujigaki, Takashi Kobayashi, et al.Surgical Endoscopy|August 6, 2017
Impact of laparoscopy on the prevention of pulmonary complications after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter studyIsao Nozaki, Junki Mizusawa, Ken Kato, et al.Journal of Cancer Research and Clinical Oncology|July 31, 2017
Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Takashi Kojima, et al.Surgery|March 10, 2019
Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinomaNaoya Okada, Hiroyuki Daiko, Jun Kanamori, et al.Japanese Journal of Clinical Oncology|August 15, 2019
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)Mitsumi Terada, Hiroki Hara, Hiroyuki Daiko, et al.International Journal of Oncology|March 4, 2020
CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancerKenji Takashima, Satoshi Fujii, Rie Komatsuzaki, et al.Pageof 22